… The WHO divides lung cancer into 2 major classes based on its … , therapy, and prognosis:
NSCLC and small cell lung cancer (see the NCCN Guidelines for Small Cell Lung Cancer, …

… Conventional treatment of non-small-cell lung cancer (NSCLC) has apparently reached a …
in the management of locally advanced and advanced disease, treatment outcomes for …

… therapy should be considered in patients with advanced non–small cell lung cancer (…
Systemic therapy has been shown to improve survival and preserve quality of life in patients with a …

… with advanced-stage non–small-cell lung cancer (NSCLC) … of the National Cancer Institute’s
Cancer Therapy Evaluation … difference in survival between treatment arms, with a median …

… Lung cancer remains a leading cause of cancer related mortality worldwide. Despite numerous
advances in treatments over the past decade, non-small cell lung cancer … treatment for all …

… Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer.
Adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1997;15:…

… lung cancer and their role in developing treatment strategies. These gain-of-function mutations
enhance EGF-R activation, markedly increase sensitivity to EGF-R RTK inhibitors and are …

… on Cancer defines stage I non-small cell lung carcinoma (NSCLC) as consisting of patients
with a T1 or T2 primary tumor … for aggressive local therapy, and curative treatment is possible. …

… Non-small cell lung cancer (NSCLC) is the most frequent cause of cancer death in the world,
… Therefore, new treatment approaches are needed. Targeting the epidermal growth factor …

… therapy has emerged as an important mean of the disease management for patients with
non-small-cell lung cancer (… trials in lung cancer. Chemotherapy is no longer the best available …